...
首页> 外文期刊>Neural regeneration research >Neuroprotective effects of tadalafil on gerbil dopaminergic neurons following cerebral ischemia
【24h】

Neuroprotective effects of tadalafil on gerbil dopaminergic neurons following cerebral ischemia

机译:他达拉非对脑缺血后沙土多巴胺能神经元的神经保护作用。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Impairment of dopamine function, which is known to have major effects on behaviors and cognition, is one of the main problems associated with cerebral ischemia. Tadalafil, a long-acting phosphodiesterase type-5 inhibitor, is known to ameliorate neurologic impairment induced by brain injury, but not in dopaminergic regions. We investigated the neuroprotective effects of treatment with tadalafil on cyclic guanosine monophosphate level and dopamine function following cerebral ischemia. Forty adult Mongolian gerbils were randomly and evenly divided into five groups (n = 8 in each group): Sham-operation group, cerebral ischemia-induced and 0, 0.1, 1, and 10 mg/kg tadalafil-treated groups, respectively. Tadalafil dissolved in distilled water was administered orally for 7 consecutive days, starting 1 day after surgery. Cyclic guanosine monophosphate assay and immunohistochemistry were performed for thyrosine hydroxylase expression and western blot analysis for dopamine D2 receptor expression. A decrease in cyclic guanosine monophosphate level following cerebral ischemia was found with an increase in thyrosine hydroxylase activity and a decrease in dopamine D2 receptor expression in the striatum and substantia nigra region. However, treatment with tadalafil increased cyclic guanosine monophosphate expression, suppressed thyrosine hydroxylase expression and increased dopamine D2 receptor expression in the striatum and substantia nigra region in a dose-dependent manner. Tadalafil might ameliorate cerebral ischemia-induced dopaminergic neuron injury. Therefore, tadalafil has the potential as a new neuroprotective treatment strategy for cerebral ischemic injury. Research Highlights (1) A phosphodiesterase type-5 inhibitor tadalafil significantly increased cyclic guanosine monophosphate level, suppressed thyrosine hydroxylase expression and increased dopamine D2 receptor expression in the striatum and substantia nigra region in a dose-dependent manner. (2) Tadalafil has the potential as a new neuroprotective treatment strategy for cerebral ischemic injury.
机译:已知对行为和认知有重​​大影响的多巴胺功能受损是与脑缺血有关的主要问题之一。他达拉非是一种长效5型磷酸二酯酶抑制剂,已知可减轻因脑损伤而引起的神经系统损害,但不能减轻多巴胺能区。我们调查了他达拉非治疗对脑缺血后环状鸟苷单磷酸水平和多巴胺功能的神经保护作用。将四十只成年蒙古沙鼠随机分为五组(每组n = 8):假手术组,脑缺血诱导的他达拉非治疗组和0、0.1、1和10 mg / kg他达拉非治疗组。从手术后1天开始,连续7天口服溶解于蒸馏水中的他达拉非。进行循环鸟苷一磷酸测定和免疫组化分析,测定酪氨酸羟化酶的表达,并用western blot分析多巴胺D 2 受体的表达。脑缺血后环状鸟苷单磷酸水平降低,其纹状体和黑质区域的酪氨酸羟化酶活性升高,多巴胺D 2 受体表达降低。然而,他达拉非治疗可增加纹状体和黑质区域环状鸟苷单磷酸的表达,抑制酪氨酸羟化酶的表达,并增加多巴胺D 2 受体的表达。他达拉非可能减轻脑缺血引起的多巴胺能神经元损伤。因此,他达拉非具有作为脑缺血性损伤的新的神经保护治疗策略的潜力。研究重点(1)磷酸二酯酶5型抑制剂他达拉非以剂量依赖性方式显着增加纹状体和黑质区域中环鸟苷单磷酸水平,抑制酪氨酸羟化酶表达并增加多巴胺D 2 受体表达。 。 (2)他达拉非具有作为脑缺血性损伤的新型神经保护治疗方法的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号